文献速递腹部MR

钆塞酸二钠增强MRI延迟门静脉期识别肝细胞癌强化包膜的价值

Gadoxetate disodium-enhanced MRI for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: late portal venous phase may improve identification of enhancing capsule.
PubMed 文献 · Abdom Radiol (NY) · 2022-12-09

回顾性分析116例慢性肝病高危患者共128个病理证实肝细胞癌,评估钆塞酸二钠增强MRI加入延迟门静脉期(平均104.4秒)对识别强化包膜的价值。结果显示加入延迟门静脉期后每位阅片者多识别7个强化包膜(P=0.016),但LI-RADS v2018诊断肝细胞癌的敏感度无显著差异。

要点

  • 延迟门静脉期(约90-119秒)可提高肝细胞癌强化包膜的识别率。
  • 强化包膜识别增加后,LI-RADS LR-5诊断敏感度未见显著提升。
  • 日常阅片可在常规门静脉期后加扫延迟门静脉期以辅助判断包膜。

局限性

  • 回顾性研究设计。
  • 单中心研究。
  • 样本量有限(116例患者、128个病灶)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate added value of late portal venous phase (LPVP) for identification of enhancing capsule (EC) on gadoxetate disodium-enhanced MRI (GD-MRI) for diagnosing hepatocellular carcinoma (HCC) in patients with chronic liver disease (CLD).

METHODS: This retrospective study comprised 116 high-risk patients with 128 pathologically proven HCCs who underwent GD-MRI including arterial phase, conventional portal venous phase (CPVP, 60 s), LPVP (mean, 104.4 ± 6.7 s; range, 90-119 s), and transitional phase (TP, 3 min). Two independent radiologists assessed the presence of major HCC features, including EC on CPVP and/or TP (CPVP/TP) and EC on LPVP. The frequency of EC was compared on GD-MRI between with and without inclusion of LPVP. The radiologists assigned Liver Imaging Reporting and Data System (LI-RADS) v2018 categories before and after identifying EC on LPVP.

RESULTS: Of the total 128 HCCs, 74 and 73 revealed EC on CPVP/TP for reviewer 1 and 2, respectively. After inclusion of LPVP, each reviewer identified seven more EC [Reviewer 1, 57.8% (74/128) vs. 63.3% (81/128); Reviewer 2, 57.0% (73/128) vs. 62.5% (80/128); P = 0.016, respectively]. Sensitivities of LR-5 assignment for diagnosing HCCs were not significantly different in GD-MRI with or without LPVP for EC identification [Reviewer 1, 71.9% (92/128) vs. 72.7% (93/128); Reviewer 2, 75.0% (96/128) vs. 75.8% (97/128); P = 1.000, respectively].

CONCLUSION: Including the LPVP in GD-MRI may improve identification of EC of HCC in patients with CLD. However, LI-RADS v2018 using GD-MRI showed comparable sensitivity for diagnosing HCC regardless of applying LPVP for EC.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Kim, Kim, Shin, et al. Gadoxetate disodium-enhanced MRI for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: late portal venous phase may improve identification of enhancing capsule. Abdom Radiol (NY). 2022. PMID: 36494608. doi:10.1007/s00261-022-03756-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。